253 related articles for article (PubMed ID: 24754826)
21. Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases: Rationale, Aims, and Design of a Nationwide Prospective Registry--The EXCITING-ILD Registry.
Kreuter M; Herth FJ; Wacker M; Leidl R; Hellmann A; Pfeifer M; Behr J; Witt S; Kauschka D; Mall M; Günther A; Markart P
Biomed Res Int; 2015; 2015():123876. PubMed ID: 26640781
[TBL] [Abstract][Full Text] [Related]
22. Elevated serum D-dimer level is associated with an increased risk of acute exacerbation in interstitial lung disease.
Ishikawa G; Acquah SO; Salvatore M; Padilla ML
Respir Med; 2017 Jul; 128():78-84. PubMed ID: 28610674
[TBL] [Abstract][Full Text] [Related]
23. Association of Preexisting Interstitial Lung Abnormalities With Immune Checkpoint Inhibitor-Induced Interstitial Lung Disease Among Patients With Nonlung Cancers.
Shimoji K; Masuda T; Yamaguchi K; Sakamoto S; Horimasu Y; Nakashima T; Miyamoto S; Iwamoto H; Fujitaka K; Hamada H; Takeno S; Hide M; Teishima J; Ohdan H; Hattori N
JAMA Netw Open; 2020 Nov; 3(11):e2022906. PubMed ID: 33180128
[TBL] [Abstract][Full Text] [Related]
24. Effect of tumor necrosis factor inhibitors on interstitial lung disease in rheumatoid arthritis: angel or demon?
Huang Y; Lin W; Chen Z; Wang Y; Huang Y; Tu S
Drug Des Devel Ther; 2019; 13():2111-2125. PubMed ID: 31308625
[No Abstract] [Full Text] [Related]
25. Management of interstitial lung disease associated with connective tissue disease.
Mathai SC; Danoff SK
BMJ; 2016 Feb; 352():h6819. PubMed ID: 26912511
[TBL] [Abstract][Full Text] [Related]
26. The risk of interstitial lung disease during biological treatment in Japanese patients with psoriasis.
Matsumoto Y; Abe N; Tobita R; Kawakami H; Nakayama H; Setoguchi Y; Tsuboi R; Okubo Y
Clin Exp Dermatol; 2020 Oct; 45(7):853-858. PubMed ID: 32356612
[TBL] [Abstract][Full Text] [Related]
27. Nivolumab-induced interstitial lung disease analysis of two phase II studies patients with recurrent or advanced non-small-cell lung cancer.
Kato T; Masuda N; Nakanishi Y; Takahashi M; Hida T; Sakai H; Atagi S; Fujita S; Tanaka H; Takeda K; Satouchi M; Namba Y; Tamura T
Lung Cancer; 2017 Feb; 104():111-118. PubMed ID: 28212992
[TBL] [Abstract][Full Text] [Related]
28. Current and Emerging Drug Therapies for Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD).
Jee AS; Corte TJ
Drugs; 2019 Sep; 79(14):1511-1528. PubMed ID: 31399860
[TBL] [Abstract][Full Text] [Related]
29. A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease.
Wong AW; Lee TY; Johannson KA; Assayag D; Morisset J; Fell CD; Fisher JH; Shapera S; Gershon AS; Cox G; Halayko AJ; Hambly N; Manganas H; Sadatsafavi M; Wilcox PG; To T; Marcoux V; Khalil N; Kolb M; Ryerson CJ
Respir Res; 2020 Dec; 21(1):322. PubMed ID: 33287805
[TBL] [Abstract][Full Text] [Related]
30. Interstitial lung diseases--where we started from and are now going.
Reynolds HY; Gail DB; Kiley JP
Sarcoidosis Vasc Diffuse Lung Dis; 2005 Mar; 22(1):5-12. PubMed ID: 15881274
[TBL] [Abstract][Full Text] [Related]
31. Gastroesophageal reflux incites interstitial lung disease in systemic sclerosis: clinical, radiologic, histopathologic, and treatment evidence.
Christmann RB; Wells AU; Capelozzi VL; Silver RM
Semin Arthritis Rheum; 2010 Dec; 40(3):241-9. PubMed ID: 20494406
[TBL] [Abstract][Full Text] [Related]
32. Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer.
Nakanishi Y; Masuda T; Yamaguchi K; Sakamoto S; Horimasu Y; Nakashima T; Miyamoto S; Tsutani Y; Iwamoto H; Fujitaka K; Miyata Y; Hamada H; Okada M; Hattori N
Respir Investig; 2019 Sep; 57(5):451-459. PubMed ID: 31248832
[TBL] [Abstract][Full Text] [Related]
33. Treatment of Interstitial Lung Disease Associated Cough: CHEST Guideline and Expert Panel Report.
Birring SS; Kavanagh JE; Irwin RS; Keogh KA; Lim KG; Ryu JH;
Chest; 2018 Oct; 154(4):904-917. PubMed ID: 30036496
[TBL] [Abstract][Full Text] [Related]
34. Interstitial lung disease is a risk factor for ischaemic heart disease and myocardial infarction.
Clarson LE; Bajpai R; Whittle R; Belcher J; Abdul Sultan A; Kwok CS; Welsh V; Mamas M; Mallen CD
Heart; 2020 Jun; 106(12):916-922. PubMed ID: 32114515
[TBL] [Abstract][Full Text] [Related]
35. Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts.
Kiely P; Busby AD; Nikiphorou E; Sullivan K; Walsh DA; Creamer P; Dixey J; Young A
BMJ Open; 2019 May; 9(5):e028466. PubMed ID: 31061059
[TBL] [Abstract][Full Text] [Related]
36. Identification of early interstitial lung disease in smokers from the COPDGene Study.
Washko GR; Lynch DA; Matsuoka S; Ross JC; Umeoka S; Diaz A; Sciurba FC; Hunninghake GM; San José Estépar R; Silverman EK; Rosas IO; Hatabu H
Acad Radiol; 2010 Jan; 17(1):48-53. PubMed ID: 19781963
[TBL] [Abstract][Full Text] [Related]
37. Reinterpreting Evidence of Rheumatoid Arthritis-Associated Interstitial Lung Disease to Understand Etiology.
Wu EK; Ambrosini RD; Kottmann RM; Ritchlin CT; Schwarz EM; Rahimi H
Curr Rheumatol Rev; 2019; 15(4):277-289. PubMed ID: 30652645
[TBL] [Abstract][Full Text] [Related]
38. The extended utility of antifibrotic therapy in progressive fibrosing interstitial lung disease.
Sarkar P; Avram C; Chaudhuri N
Expert Rev Respir Med; 2020 Oct; 14(10):1001-1008. PubMed ID: 32567402
[TBL] [Abstract][Full Text] [Related]
39. Independent review of interstitial lung disease associated with death in TRIBUTE (paclitaxel and carboplatin with or without concurrent erlotinib) in advanced non-small cell lung cancer.
Yoneda KY; Shelton DK; Beckett LA; Gandara DR
J Thorac Oncol; 2007 Jun; 2(6):537-43. PubMed ID: 17545850
[TBL] [Abstract][Full Text] [Related]
40. A retrospective analysis of distinguishing features of chest HRCT and clinical manifestation in primary Sjögren's syndrome-related interstitial lung disease in a Chinese population.
Dong X; Zhou J; Guo X; Li Y; Xu Y; Fu Q; Lu Y; Zheng Y
Clin Rheumatol; 2018 Nov; 37(11):2981-2988. PubMed ID: 30242640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]